210421-71-9

Basic information

• Product Name: 3-(N-(4-chloro-3-Methylisoxazol-5-yl)sulfaMoyl)-N-Methoxy-N-Methylthiophene-2-carboxaMide
• Synonyms: 3-(N-(4-chloro-3-Methylisoxazol-5-yl)sulfaMoyl)-N-Methoxy-N-Methylthiophene-2-carboxaMide;N-Methoxy-N-methyl-3-(4-chloro-3-methyl-5-isoxazolylsulfamoyl)-2-thiophenecarboxamide
• CAS NO: 210421-71-9
• Molecular Formula: C₁₁H₁₂ClN₃O₅S₂
• Molecular Weight: 365.81308
• Mol File: 210421-71-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 588.217°C at 760 mmHg
• Flash Point: 309.543°C
• Appearance: /
• Density: 1.563±0.06 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.613
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-(N-(4-chloro-3-Methylisoxazol-5-yl)sulfaMoyl)-N-Methoxy-N-Methylthiophene-2-carboxaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(N-(4-chloro-3-Methylisoxazol-5-yl)sulfaMoyl)-N-Methoxy-N-Methylthiophene-2-carboxaMide(210421-71-9)
• EPA Substance Registry System: 3-(N-(4-chloro-3-Methylisoxazol-5-yl)sulfaMoyl)-N-Methoxy-N-Methylthiophene-2-carboxaMide(210421-71-9)

Safety Data

• Hazardous Substances Data: 210421-71-9(Hazardous Substances Data)

Usage

General Description

The chemical 3-(N-(4-chloro-3-Methylisoxazol-5-yl)sulfaMoyl)-N-Methoxy-N-Methylthiophene-2-carboxaMide, also known as CMIT/MIT, is a potent biocide used in various industrial applications such as water treatment, personal care products, and paints. It is a combination of two active ingredients, chloromethylisothiazolinone (CMIT) and methylisothiazolinone (MIT), that work together to inhibit the growth of bacteria, fungi, and algae. CMIT/MIT is effective over a wide pH range and at low concentrations, making it a popular choice for microbial control in many different settings. However, it is important to handle and use CMIT/MIT carefully as it can cause irritation and allergic reactions in some individuals.

InChI:InChI=1/C11H12ClN3O5S2/c1-6-8(12)10(20-13-6)14-22(17,18)7-4-5-21-9(7)11(16)15(2)19-3/h4-5,14H,1-3H3

Upstream product

• 59337-92-7 2-(carbomethoxy)thiophene-3-sulfonyl chloride 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 184040-74-2 3{[(4-chloro-3-methyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxylic acid 

Downstream Products

• 184036-34-8 sitaxentan 

Relevant articles and documents

SITAXENTAN DERIVATIVE

A compound represented by formula (1-1) or (1-2), or a pharmacologically acceptable salt thereof retains the principal therapeutic effect of sitaxentan and has an improved CYP inhibitory effect: wherein R1 is a halogen atom, etc., R2 is a methyl group, etc., R3 is a C1-6 alkyl group, etc., and M is a group represented by: etc.

Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist

Previously we reported the discovery of amidothiophenesulfonamides as endothelin receptor-A antagonists with high potency and selectivity. Replacement of an amide group in this class of compounds with an acetyl group maintained the in vitro binding affinity and in vivo activity while providing a compound with oral bioavailability and longer duration of action. The optimal compound discovered during these studies, 15q (TBC11251), binds competitively to human ET(A) receptors with a K(i) of 0.43 ± 0.03 nM and an IC50 of 1.4 nM (IC50 for ET(B) = 9800 nM). This compound inhibits ET-1- induced stimulation of phosphoinositide turnover with a K(i) of 0.686 nM and a pA2 of 8.0. The compound has a serum half-life in the rat and the dog of 6-7 h and 60-100% oral bioavailability. This compound is one of the most selective ET(A) antagonists reported and therefore is suitable for additional pharmacological and clinical investigation of the role of ET(A) receptors in diseases.